LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Mutant recombinant hemoglobins containing heme pocket mutations

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Mutants of bone morphogenetic proteins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Mutants of bone morphogenetic proteins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Mutants of bone morphogenetic proteins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Mutated anthrax toxin protective antigen proteins that...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Mutated HOXB4 proteins with improved stability, and methods...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Mutated steroid hormone receptors, methods for their use and mol

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Mutations in the gene encoding the alpha chain of platelet glyco

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of bilin-binding protein

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of epidermal growth factor exhibiting enhanced...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of fibroblast growth factor 21

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of fibroblast growth factor 21

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of fibroblast growth factor 21

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of human epidermal growth factor exhibiting enhanced bin

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of human erythropoietin, the preparation thereof and the

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of IFN-.beta.

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Muteins of the CGRP 1-7 peptide fragment and use thereof as...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Mutilin derivatives and their use as antibacterials

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Mutual prodrug of amlodipine and atorvastatin